Calpain protease causes hypoxia-induced proteolysis in cultured human Retina

Current Eye Research

Volumn 39, Issue 4, 2014, Pages 421-424

  Azuma, Mitsuyoshi ^a,b   Hammond, Katherine B ^a   Nakajima, Emi ^a,b   Shearer, Thomas R ^b  

^a Senju Laboratory of Ocular Sciences Senju Pharmaceutical Co Ltd   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Calpain; Calpain inhibitor; Human retina; Hypoxia; Non human primate retina; Proteolysis

Indexed keywords

CALPAIN; FODRIN; OPSIN; OPSIN 1; OXYGEN; UNCLASSIFIED DRUG; VIMENTIN; [1 [(1 BENZYL 3 CYCLOPROPYLAMINO 2,3 DIOXOPROPYL)CARBAMOYL] 3 METHYLBUTYL]CARBAMIC ACID 2 (2 METHOXYETHOXY)ETHYL ESTER; ((1S)-1-((((1S)-1-BENZYL-3-CYCLOPROPYLAMINO-2,3-DI-OXOPROPYL)AMINO)CARBONYL)-3-METHYLBUTYL)CARBAMIC ACID 5-METHOXY-3-OXAPENTYL ESTER; CARBAMIC ACID DERIVATIVE; PEPTIDE HYDROLASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL HYPOXIA; CELL PROTECTION; CONTROLLED STUDY; GAS; HAPLORHINI; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MUELLER CELL; NONHUMAN; PHOTORECEPTOR; PHOTORECEPTOR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; REOXYGENATION; RETINA; AGED; ANIMAL; ANOXIA; ANTAGONISTS AND INHIBITORS; CELL DEATH; DISEASE MODEL; DRUG EFFECTS; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANIMALS; ANOXIA; CALPAIN; CARBAMATES; CELL DEATH; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; HAPLORHINI; HUMANS; IMMUNOBLOTTING; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PROTEOLYSIS; RETINA;

EID: 84896282902     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2013.845225     Document Type: Article

References (11)

1. Caprara C, Grimm C. From oxygen to erythropoietin: relevance of hypoxia for retinal development, health and disease. Prog Retin Eye Res 2012;31:89-119.
2. Azuma M, Shearer TR. The role of calcium-activated protease calpain in experimental retinal pathology. Surv Ophthalmol 2008;53:150-163.
3. Sakamoto Y, Nakajima T, Fukiage C, Sakai O, Yoshida Y, Azuma M, et al. Involvement of calpain isoforms in ischemia-reperfusion injury in rat retina. Curr Eye Res 2000;21:571-580.
4. Oka T, Walkup RD, Tamada Y, Nakajima E, Tochigi A, Shearer TR, et al. Amelioration of retinal degeneration and proteolysis in acute ocular hypertensive rats by calpain inhibitor ((1S)-1-((((1S)-1-benzyl-3- cyclopropylamino- 2,3-di-oxopropyl) amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester. Neuroscience 2006;141:2139-2145.
5. Tamada Y, Fukiage C, Daibo S, Yoshida Y, Azuma M, Shearer TR. Involvement of calpain in hypoxia-induced damage in rat retina in vitro. Comp Biochem Physiol B Biochem Mol Biol 2002;131:221-225.
6. Nakajima E, David LL, Bystrom C, Shearer TR, Azuma M. Calpain-specific proteolysis in primate retina: contribution of calpains in cell death. Invest Ophthalmol Vis Sci 2006;47: 5469-5475.
7. Nakajima E, Hammond KB, Rosales JL, Shearer TR, Azuma M. Calpain, not caspase, is the causative protease for hypoxic damage in cultured monkey retinal cells. Invest Ophthalmol Vis Sci 2011;52:7059-7067.
8. Paquet-Durand F, Johnson L, Ekstro?m P. Calpain activity in retinal degeneration. J Neurosci Res 2007;85:693-702. Review.
9. Sims NR, Muyderman H. Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta 2010; 1802:80-91. Review.
10. Shirasaki Y, Yamaguchi M, Miyashita H. Retinal penetration of calpain inhibitors in rats after oral administration. J Ocul Pharmacol Ther 2006;22:417-424.
11. Moldoveanu T, Gehring K, Green DR. Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains. Nature 2008;20: 404-408.